NCT01691209View on ClinicalTrials.gov

Efficacy/Safety Study to Explore a New Topical Formulation in Atopic Dermatitis

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

October 31, 2013

Primary Completion Date

April 30, 2014

Study Completion Date

June 30, 2014

Conditions
Dermatitis, Atopic
Interventions
DEVICE

Phoenix (BAY81-2996)

Topical formulation applied to the skin

DRUG

1% Hydrocortison cream

1% Hydrocortison cream applied to the skin

Trial Locations (1)

48155

Münster

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY